Riskpilot← Back to searchSign inGet full accessSuomen Lääkevarmennus Oy
OYActiveY-tunnus 2801478-9Itämerentori 2All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 20165 employees
Revenue 2025
EUR 1,8M
-9% vs 2024
EBITDA margin
-4.1%
+70% vs 2024
Equity ratio
76.2%
Financial strength
Net profit 2025
EUR -62K
+73% vs 2024
| Revenue | EUR 1,8M | -9% |
| EBITDA | EUR -74K | +70% |
| Net profit | EUR -62K | +73% |
| Total assets | EUR 1,2M | -7% |
| Equity | EUR 896K | -7% |
| Employees | 5 | — |
Legal name
Suomen Lääkevarmennus Oy
Y-tunnus number
2801478-9
Legal form
Osakeyhtiö
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
19. joulukuuta 2016
Share capital
EUR 10 020
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on Euroopan unionin lääkeväärennösdirektiivissä (2011/62/EU) edellytettyjen lääkepakkausten turvamerkintöjen hallinnoimiseksi perustettavaan lääkevarmennusjärjestelmään liittyvien palveluiden tuottaminen ja tarjoaminen, kyseisen järjestelmän kehittäminen, siihen liittyvä hallinnointi, neuvonta ja hallinnointipalveluiden tuottaminen sekä muu lääkevarmennusjärjestelmään liittyvä toiminta.
Address
Itämerentori 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 826 | 2 054 | 2 054 | 1 994 | 1 818 |
| Staff expenses | −403 | −440 | −440 | −642 | −586 |
| EBITDA | 328 | 451 | 451 | −245 | −74 |
| Depreciation & amort. | −202 | — | −0 | −0 | −0 |
| EBIT | 126 | 451 | 451 | −245 | −74 |
| Net financials | 8 | −13 | −13 | 13 | 11 |
| Profit before tax | 135 | 438 | 439 | −232 | −62 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 135 | 438 | 439 | −232 | −62 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 400 | 1 637 | 1 637 | 1 259 | 1 177 |
| Equity | 954 | 1 393 | 1 393 | 959 | 896 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 446 | 244 | 244 | 300 | 281 |
| Total debt | 446 | 244 | 244 | 300 | 281 |
EBITDA margin
-4.1%
This company
15.8%
Market median
-126% vs market
20212025
Equity ratio
76.2%
This company
38.2%
Market median
+99% vs market
20212025
Return on equity
-7.0%
This company
18.4%
Market median
-138% vs market
20212025
Net profit margin
-3.4%
This company
8.1%
Market median
-142% vs market
20212025
Asset turnover
1.54×
This company
1.12×
Market median
+37% vs market
20212025
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (7) | ||
AV Deputy Member | Deputy Member | 2024 |
TR Deputy Member | Deputy Member | 2018 |
MM Chief Executive Officer | Chief Executive Officer | 2016 |
MJ Deputy Member | Deputy Member | 2024 |
PJ Deputy Member | Deputy Member | 2022 |
KM Deputy Member | Deputy Member | 2025 |
SS Deputy Member | Deputy Member | 2023 |
| Former (7) | ||
AJ Audit | Audit | 2016 – 2019 |
RA Deputy Member | Deputy Member | 2022 – 2023 |
AA Deputy Member | Deputy Member | 2019 – 2022 |
VS Deputy Member | Deputy Member | 2018 – 2019 |
SA Deputy Member | Deputy Member | 2018 – 2024 |
TM Deputy Member | Deputy Member | 2020 – 2022 |
KM Audit | Audit | 2019 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2024 | |
| Board of Directors | 2018 | |
| Board of Directors | 2022 | |
| Board of Directors | 2025 | |
| Chairperson | 2025 | |
| Former (7) | ||
| Board of Directors | 2018 – 2020 | |
| Board of Directors | 2021 – 2022 | |
| Chairperson | 2018 – 2025 | |
| Board of Directors | 2019 – 2024 | |
| Board of Directors | 2018 – 2020 | |
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2018 – 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Suomen Lääkevarmennus Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne-Mari Virolainen | Deputy Member | 0 companies |
| Tommie Rickard Jern | Deputy Member | 0 companies |
| Anders Johan Svennas | Audit | 0 companies |
| Maija Maria Gohlke | Chief Executive Officer | 0 companies |
| Roosa Anneli Niemelä | Deputy Member | 0 companies |
| Aino Anna Liisa Hurme | Deputy Member | 0 companies |
| Mika Juhani Kuivamäki | Deputy Member | 0 companies |
| Virve Susanna Laitinen | Deputy Member | 0 companies |
| Sanna-Liisa Aunesluoma | Deputy Member | 0 companies |
| Pekka Juhani Kankaanpää | Deputy Member | 0 companies |
| Kai Mauri Kaasalainen | Deputy Member | 0 companies |
| Sami Sebastian Saari | Deputy Member | 0 companies |
| Tuula Marjatta Lehto | Deputy Member | 0 companies |
| Kirsi Marja Aromäki | Audit | 0 companies |
| Sampsa Edvard Kavander | Board of Directors | 0 companies |
| Inka Ilona Puumalainen | Board of Directors | 0 companies |
| Johanna Linnea Pakkanen | Board of Directors | 0 companies |
| Tia Annette Geijer | Board of Directors | 0 companies |
| Heikki Juhani Bothas | Board of Directors | 0 companies |
| Nina Maria Ekholm-Wenberg | Chairperson | 0 companies |
| Sanna Johanna Raappana | Board of Directors | 0 companies |
| Petter Johannes Sandström | Board of Directors | 0 companies |
| Charlotta Sandler | Board of Directors | 0 companies |
| Annastiina Palmroth-Holst | Board of Directors | 0 companies |
| Juho Oskari Hellman | Board of Directors | 0 companies |
| Kirsi Maarit Helena Pietilä | Board of Directors | 0 companies |
| Ritva Helena Lehtonen | Chairperson | 0 companies |